ConductScience.org, home

Paper269683

Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy.

Pollack MA and 2 others. Arch Neurol, 1977. Cited by 66 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy. Papers, record 269683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/269683

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy.
PubMed
Journal
Arch Neurol
PubMed
Year
1977
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
3.12
iCite
Revised in PubMed
2019-07-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pollack MAM A
2Cohen NLN L
3Friedhoff AJA J

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethylphenidateMajor topic
Tourette SyndromeMajor topic
Adult
Child
Dextroamphetamine
Haloperidol
Humans
Hyperkinesis
Male
Pedigree

Source PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
25,120,227A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.CNS Drugs2014https://conductscience.org/library/papers/25120227PubMed
11,772,131Pharmacological options for the treatment of Tourette's disorder.Drugs2001https://conductscience.org/library/papers/11772131PubMed
11,393,328Tourette syndrome: clinical characteristics and current management strategies.Paediatr Drugs2001https://conductscience.org/library/papers/11393328PubMed
11,140,781Gilles de la Tourette syndrome: symptomatic treatment based on evidence.Eur Child Adolesc Psychiatry2000https://conductscience.org/library/papers/11140781PubMed
7,911,827PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.J Neurol Neurosurg Psychiatry1994https://conductscience.org/library/papers/7911827PubMed
6,956,751Tourette's syndrome in a black woman with associated triple X and 9p mosaicism.J Natl Med Assoc1982https://conductscience.org/library/papers/6956751PubMed
6,587,774Detection of major gene for Gilles de la Tourette syndrome.Am J Hum Genet1984https://conductscience.org/library/papers/6587774PubMed
6,573,436Gilles de la Tourette's syndrome in monozygotic twins.J Neurol Neurosurg Psychiatry1983https://conductscience.org/library/papers/6573436PubMed
3,522,904Gilles de la Tourette syndrome: a review.J R Soc Med1986https://conductscience.org/library/papers/3522904PubMed
2,890,294A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems.Am J Hum Genet1987https://conductscience.org/library/papers/2890294PubMed
281,939Significance of genetic factors in Gilles de la Tourette syndrome: a review.Behav Genet1978https://conductscience.org/library/papers/281939PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/269683

GET https://conductscience.org/api/papers/v1/269683/authors